BRIDGEWATER, N.J., June 5, 2024
/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global
biopharmaceutical company on a mission to transform the lives of
patients with serious and rare diseases, today announced that
management will present in a fireside chat at the Goldman Sachs
45th Annual Global Healthcare Conference in Miami on Monday, June
10, 2024, at 10:00 a.m.
ET.
The fireside chat will be webcast live and can be accessed by
visiting the investor relations section of the Company's website at
www.insmed.com. The webcast will be archived for a period of 30
days following the conclusion of the live event.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases. Insmed's first commercial product is a first-in-disease
therapy approved in the United
States, Europe, and
Japan to treat a chronic,
debilitating lung disease. The Company is progressing a robust
pipeline of investigational therapies targeting areas of serious
unmet need, including neutrophil-mediated inflammatory diseases and
rare pulmonary disorders. Insmed is also advancing an early-stage
research engine encompassing a wide range of technologies and
modalities, including artificial intelligence-driven protein
engineering, gene therapy, and protein manufacturing. Insmed is
headquartered in Bridgewater, New
Jersey, with additional offices and research locations
throughout the United States,
Europe, and Japan. Visit www.insmed.com to learn more.
Contact:
Investors:
Bryan Dunn
Executive Director, Investor
Relations
Insmed
(646)
812-4030
bryan.dunn@insmed.com
Eleanor Barisser
Associate Director, Investor
Relations
Insmed
(718)
594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Executive Director, Corporate
Communications
Insmed
(732)
718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-to-present-at-the-goldman-sachs-45th-annual-global-healthcare-conference-302163361.html
SOURCE Insmed Incorporated